Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Yexiong Tan"'
Autor:
Zhiwen Ding, Yufei Pan, Taiyu Shang, Tianyi Jiang, Yunkai Lin, Chun Yang, Shujie Pang, Xiaowen Cui, Yixiu Wang, Xiao fan Feng, Mengyou Xu, Mengmiao Pei, Yibin Chen, Xin Li, Jin Ding, Yexiong Tan, Hongyang Wang, Liwei Dong, Lu Wang
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-20 (2023)
Abstract The clinical benefit of tyrosine kinase inhibitors (TKIs)-based systemic therapy for advanced hepatocellular carcinoma (HCC) is limited due to drug resistance. Here, we uncover that lipid metabolism reprogramming mediated by unconventional p
Externí odkaz:
https://doaj.org/article/d8e1ba2f0a004db2be4eaffc220459c3
Autor:
Yanping Wei, Jingbo Fu, Hailing Zhang, Yan Ling, Xuewu Tang, Shuowu Liu, Miao Yu, Fuyan Liu, Guokun Zhuang, Haihua Qian, Kecheng Zhang, Pinhua Yang, Xinwei Yang, Qi Yang, Shennian Ge, Baohua Zhang, Yexiong Tan, Liang Li, Hongyang Wang
Publikováno v:
iScience, Vol 26, Iss 10, Pp 108022- (2023)
Summary: CircRNAs play multiple roles in a variety of cellular processes. We found that Circ-CDYL is highly enriched in early HCC plasma exosomes. Moreover, EpCAM+ HCC cells and exosomes had significant Circ-CDYL levels. We postulated that Circ-CDYL-
Externí odkaz:
https://doaj.org/article/c1668e761fdc4c3f82491157364d52e0
Autor:
Taiyu Shang, Tianyi Jiang, Tao Lu, Hui Wang, Xiaowen Cui, Yufei Pan, Mengyou Xu, Mengmiao Pei, Zhiwen Ding, Xiaofan Feng, Yunkai Lin, Xin Li, Yexiong Tan, Feiling Feng, Hui Dong, Hongyang Wang, Liwei Dong
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionCholangiocarcinoma (CCA) is a malignant tumor of the biliary epithelium with a poor prognosis. The lack of biomarkers to predict therapeutic response and prognosis is one of the major challenges for CCA treatment. Tertiary lymphoid struct
Externí odkaz:
https://doaj.org/article/c18e8293787747dc8811e47b48ff5dfa
Autor:
Yuanyuan Shi, Xiaowen Cui, Tianyi Jiang, Yufei Pan, Yunkai Lin, Xiaofan Feng, Zhiwen Ding, Chun Yang, Yexiong Tan, Hongyang Wang, Liwei Dong
Publikováno v:
Cell Death and Disease, Vol 13, Iss 9, Pp 1-13 (2022)
Abstract Cholangiocarcinoma (CCA) is an epithelial malignancy with a dismal prognosis owing to limited treatment options. Here, we identified several compound candidates against CCA using a high-throughput drug screen with approved or emerging oncolo
Externí odkaz:
https://doaj.org/article/3d693245a32f489c843ca438c0edea68
Autor:
Shilei Bai, Pinghua Yang, Yanping Wei, Jie Wang, Caixia Lu, Yong Xia, Anfeng Si, Baohua Zhang, Feng Shen, Yexiong Tan, Kui Wang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Background and AimThe prediction models of postoperative survival for hepatitis B virus-related hepatocellular carcinoma (HBV-HCC) with microvascular invasion (MVI) have not been well established. The study objective was the development of nomograms
Externí odkaz:
https://doaj.org/article/3d8159deaf1a444c84a110eafbbc70fb
Autor:
Yanping Wei, Xuewu Tang, Yibin Ren, Yun Yang, Fengliang Song, Jingbo Fu, Shuowu Liu, Miao Yu, Jing Chen, Suyang Wang, Kecheng Zhang, Yexiong Tan, Zhipeng Han, Lixin Wei, Baohua Zhang, Zhangjun Cheng, Liang Li, Hongyang Wang
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-13 (2021)
Abstract Hepatocellular carcinoma (HCC) is the global leading cause of cancer-related deaths due to the deficiency of targets for precision therapy. A new modality of epigenetic regulation has emerged involving RNA–RNA crosstalk networks where two
Externí odkaz:
https://doaj.org/article/d9bce90774ac4f168a9935a686a2c9cd
Autor:
Qingqing Wang, Yexiong Tan, Tianyi Jiang, Xiaolin Wang, Qi Li, Yanli Li, Liwei Dong, Xinyu Liu, Guowang Xu
Publikováno v:
Cells, Vol 11, Iss 7, p 1066 (2022)
Hepatocarcinogenesis is frequently accompanied by substantial metabolic reprogramming to maximize the growth and proliferation of cancer cells. In this study, we carried out a comprehensive study of metabolomics and lipidomics profiles combined with
Externí odkaz:
https://doaj.org/article/3c00385c0b034aaab99bd11e46b775b4
Autor:
Chengnan Fang, Hui Wang, Zhikun Lin, Xinyu Liu, Liwei Dong, Tianyi Jiang, Yexiong Tan, Zhen Ning, Yaorui Ye, Guang Tan, Guowang Xu
Publikováno v:
Cancers, Vol 14, Iss 1, p 231 (2022)
Hepatocellular carcinoma (HCC) displays a high degree of metabolic and phenotypic heterogeneity and has dismal prognosis in most patients. Here, a gas chromatography–mass spectrometry (GC-MS)-based nontargeted metabolomics method was applied to ana
Externí odkaz:
https://doaj.org/article/354b783c7a3f4bf7b7d5698008b6cd91
Autor:
Haiyang Chen, Zaili Luo, Liwei Dong, Yexiong Tan, Jiamei Yang, Gensheng Feng, Mengchao Wu, Zhong Li, Hongyang Wang
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e56878 (2013)
CD133/Prominin-1 is a pentaspan transmembrane protein that has been frequently used as a biomarker for cancer stem cells, although its biological function is unclear. The aim of our study was to explore the intrinsic functions of CD133 membrane prote
Externí odkaz:
https://doaj.org/article/606dc65bb2ec44a39eb6b90ba36ad25b
Autor:
Guowang Xu, Hongyang Wang, Xin Lu, Peng Gao, Guozhu Ye, Peiyuan Yin, Yexiong Tan, Qiang Huang
PDF file, 321K, Serum pretreatment for CE-MS analysis Detailed conditions of capillary electrophoresis and mass spectrometry for betaine and propionylcarnitine analysis Tables S1-S5 Figure S1. Metabolic profiling of liver tissues. Figure S2. Study of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::874f3e32f19da5b737fbafb98765c6c8
https://doi.org/10.1158/0008-5472.22401914
https://doi.org/10.1158/0008-5472.22401914